Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;20(3):232-245.
doi: 10.2174/011574888X295488240319111911.

The Application of Photobiomodulation on Mesenchymal Stem Cells and its Potential Use for Tenocyte Differentiation

Affiliations
Review

The Application of Photobiomodulation on Mesenchymal Stem Cells and its Potential Use for Tenocyte Differentiation

Brendon Roets et al. Curr Stem Cell Res Ther. 2025.

Abstract

Tendinopathy is a prevalent and debilitating musculoskeletal disorder. Uncertainty remains regarding its pathophysiology, but it is believed to be a combination of inflammation, damage, degenerative changes, and unsuccessful repair mechanisms. Cell-based therapy is an emerging regenerative medicine modality that uses mesenchymal stem cells (MSCs), their progeny or exosomes to promote tendon healing and regeneration. It is based on the fact that MSCs can be differentiated into tenocytes, the major cell type within tendons, and facilitate tendon repair. Photobiomodulation (PBM) is a non-invasive and potentially promising therapeutic technique that utilizes low-level light to alter intracellular processes and promote tissue healing and regeneration. Recent studies have examined the potential for PBM to improve MSC therapy use in tendinopathy by promoting viability, proliferation, and differentiation. As well as enhance tendon regeneration. This review focuses on Photobiomodulation and MSC therapy applications in regenerative medicine and their potential for tendon tissue engineering.

Keywords: Tendinopathy; mesenchymal stem cells; photobiomodulation; regenerative medicine; tenogenic differentiation; tissue engineering..

PubMed Disclaimer

Similar articles

Cited by

References

    1. van Dijk C.N.; van Sterkenburg M.N.; Wiegerinck J.I.; Karlsson J.; Maffulli N.; Terminology for Achilles tendon related disorders. Knee Surg Sports Traumatol Arthrosc 2011,19(5),835-841 - DOI - PubMed
    1. Xu Y.; Murrell G.A.C.; The basic science of tendinopathy. Clin Orthop Relat Res 2008,466(7),1528-1538 - DOI - PubMed
    1. Saunders C.J.; van der Merwe L.; Posthumus M.; Cook J.; Handley C.J.; Collins M.; September A.V.; Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations. J Orthop Res 2013,31(4),632-637 - DOI - PubMed
    1. Wang Y.; Zhou H.; Nie Z.; Cui S.; Prevalence of Achilles tendinopathy in physical exercise: A systematic review and meta-analysis. Sports Medicine and Health Science 2022,4(3),152-159 - DOI - PubMed
    1. Florit D.; Pedret C.; Casals M.; Malliaras P.; Sugimoto D.; Rodas G.; Incidence of tendinopathy in team sports in a multidisciplinary sports club over 8 seasons. J Sports Sci Med 2019,18(4),780-788 - PubMed

LinkOut - more resources